Register entry

Exeltis USA, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
11
Labeller names
2
Live patents
30
Countries
0
Catalogue

Drug listings by form and route

11

11 active NDC listings: 11 human prescription drug. By marketing category: UNAPPROVED DRUG OTHER 6, NDA 5.

Dosage formNDCs
kit4
tablet3
capsule, liquid filled2
capsule, gelatin coated1
gel1
RouteNDCs
oral6
topical1
Labeller name on the listingNDCs
exeltis usa, inc.10
exeltis usa, inc1
Exclusivity

Patents and exclusivities

30
PatentProductCoversExpiry
10179140DROSPIRENONE, SLYNDdrospirenoneuseJun 2031
10603281DROSPIRENONE, SLYNDdrospirenoneuseJun 2031
10849857DROSPIRENONE, SLYNDdrospirenoneproductJun 2031
10987364DROSPIRENONE, SLYNDdrospirenoneproductJun 2031
11123299DROSPIRENONE, SLYNDdrospirenoneproductJun 2031
11291632DROSPIRENONE, SLYNDdrospirenoneproductJun 2031
11291633DROSPIRENONE, SLYNDdrospirenoneproductJun 2031
11351122DROSPIRENONE, SLYNDdrospirenoneproductJun 2031
11413249DROSPIRENONE, SLYNDdrospirenoneuseJun 2031
11439598DROSPIRENONEdrospirenoneproductJun 2031
11478487DROSPIRENONE, SLYNDdrospirenoneproductJun 2031
11504334DROSPIRENONE, SLYNDdrospirenoneproductJun 2031
11951213DROSPIRENONE, SLYNDdrospirenoneuseJun 2031
12090231DROSPIRENONE, SLYNDdrospirenoneuseJun 2031
12280151SLYNDdrospirenoneproductJun 2031
9603860DROSPIRENONE, SLYNDdrospirenoneuseJun 2031
Catalogue

Marketed products

11
BrandGeneric nameForm / routeNDC
Benznidazolebenznidazoletablet, oral0642-7463NDA
Benznidazolebenznidazoletablet, oral0642-7464NDA
Nuvessametronidazolegel, topical0642-7466NDA
SLYNDDrospirenonekit0642-7470NDA
Select-OB Plus DHA Prenatal Supplement Plus DHA.BETA.-CAROTENE, VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, Thiamine Mononitrate, Riboflavin, NIACINAMIDE, Pyridoxine Hydrochloride, Folic Acid, LEVOMEFOLATE CALCIUM, Cobalamin, Iron, MAGNESIUM OXIDE, ZINC OXIDE, and DOCONEXANTkit0642-0075UNAPPROVED DRUG OTHER
Strovite One CapletsVitamin A, Calcium Pantothenate, Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Succinate, D-, Thiamine, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Folic Acid, Biotin, Cyanocobalamin, Selenium, Magnesium Oxide, Zinc Oxide, Cupric Sulfate, Manganese, Chromium, .Alpha.-Lipoic Acid, and Luteintablet, oral0642-0207UNAPPROVED DRUG OTHER
TyblumeLevonorgestrel and Ethinyl Estradiolkit0642-7471NDA
Vitafol Fe PlusDOCONEXENT, NIACINAMIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, CHOLECALCIFEROL, BETA CAROTENE, ASCORBIC ACID, THIAMINE MONONITRATE, Riboflavin, Pyridoxine Hydrochloride, CYANOCOBALAMIN, Iron, ZINC OXIDE, CUPRIC OXIDE, POTASSIUM IODIDE, MAGNESIUM OXIDE, Folic Acid, and LEVOMEFOLATE CALCIUMcapsule, liquid filled, oral0642-7473UNAPPROVED DRUG OTHER
Vitafol OnePrenatal Supplement with DHAcapsule, gelatin coated, oral0642-0070UNAPPROVED DRUG OTHER
Vitafol UltraDoconexent, Niacinamide, .Alpha.-Tocopherol Acetate, DL-, Cholecalciferol, .Beta.-Carotene, Ascorbic Acid, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Cyanocobalamin, Iron, Zinc Oxide, Cupric Oxide, Potassium Iodide, Magnesium Oxide, Folic Acid, and Levomefolate Calciumcapsule, liquid filled, oral0642-0093UNAPPROVED DRUG OTHER
Vitafol-OB Plus DHA Prenatal Supplement Plus DHAVitamin A, Ascorbic Acid, Vitamin D, .Alpha.-Tocopherol, Thiamine Mononitrate, Riboflavin, Niacin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Calcium, Iron, Magnesium, Zinc, Copper, and Doconexentkit0642-0076UNAPPROVED DRUG OTHER
Enquiry

Common questions

Is Exeltis USA, Inc. FDA approved?
Exeltis USA, Inc. holds no registered establishment of its own; 11 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Exeltis USA, Inc. make?
11 products are listed under Exeltis USA, Inc. in the openFDA NDC Directory, most often as kit; tablet; capsule, liquid filled. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.